trial

Genetic Study of Schizophrenia

NCTId NCT00001486

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Completed

Enrollment 4,914 (actual)

Sponsored by National Institute of Mental Health (NIMH)

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Completed

Enrollment

4,914 (actual)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

1995-07-15

Primary completion

—

Eligibility

ALL · 18 Years · 55 Years

Interventions & indications

Drugs

—

Indications

Hallucinations Schizoaffective Disorder Psychotic Disorders Schizophrenia Delusions Schizophrenia

Investigators

Karen F Berman, M.D.Principal Investigator

Sites

1 total

Bethesda, United States

Facts & assertions

3 sourced

Enrollment

4,914

Phase

Status

COMPLETED

relationships

The graph out of here

lead_sponsor

National Institute of Mental Health (NIMH)

company

collaborator

National Institutes of Health Clinical Center (CC)

company

indication

Hallucinations

indication

Schizoaffective Disorder

indication

Psychotic Disorders

indication

investigator

Karen F Berman, M.D.

person